MEDINCELL (EPA:MEDCL) | WebDisclosure

Basculer en Français

10387	Companies
216934	Keywords
146630	Articles
114868	Press releases

Home
Companies
MEDINCELL

PRESS RELEASE

published on 08/20/2024 at 17:47, 1 year 8 months ago

Modalités de mise à disposition des documents préparatoires à l'AG
Medincell annonce les modalités de participation à l'Assemblée Générale Mixte des actionnaires le 12 septembre 2024. Vote en ligne, vidéoconférence le 4 septembre 2024. Documents disponibles sur www.medincell.com/fr/assemblee-generale/

Actionnaires Assemblée Générale Documents Medincell Vote En Ligne
PRESS RELEASE

published on 08/20/2024 at 17:47, 1 year 8 months ago

Terms of availability of the preparatory documents for the GM
Medincell announces participation terms in the Combined General Meeting on September 12, 2024, including remote voting options, video conference for shareholders, and document availability

Shareholders Combined General Meeting Remote Voting Medincell Participation Terms
BRIEF

published on 06/28/2024 at 07:35, 1 year 10 months ago

H.C. Wainwright & Co. Initiates MedinCell’s Coverage with "Buy" Recommendation

FDA Approval BUY Rating Biopharmaceuticals H.C. Wainwright & Co. Medincell
BRIEF

published on 06/28/2024 at 07:35, 1 year 10 months ago

HC Wainwright & Co. lance la couverture de MedinCell avec une recommandation « d'achat »

Produits Biopharmaceutiques Approbation De La FDA Acheter Une Note Medincell HC Wainwright & Co.
PRESS RELEASE

published on 06/28/2024 at 07:30, 1 year 10 months ago

Inside Information / Other news releases
H.C. Wainwright & Co. initiates coverage of MedinCell with a 'Buy' recommendation at €24 price target, reflecting +80% potential increase. MedinCell achieves milestones with FDA approvals, positive Phase 3 results, and collaboration with AbbVie

FDA Approval Coverage Initiation H.C. Wainwright & Co. Medincell Pharmaceutical Sector
PRESS RELEASE

published on 06/28/2024 at 07:30, 1 year 10 months ago

Informations privilégiées / Autres communiqués
H.C. Wainwright & Co. initie la couverture de Medincell avec une recommandation à l'achat, renforçant ainsi la visibilité de l'entreprise sur le marché américain. Medincell franchit des étapes clés avec des produits innovants et des accords stratégiques

Biopharmaceutique H.C. Wainwright & Co. Recommandation À L'achat Medincell Accords Stratégiques
BRIEF

published on 06/11/2024 at 09:05, 1 year 11 months ago

Medincell Joins Euronext Tech Leaders Index

Innovation Tech Sector Investor Visibility Medincell Euronext Tech Leaders
BRIEF

published on 06/11/2024 at 09:05, 1 year 11 months ago

Medincell rejoint l'indice Euronext Tech Leaders

Innovation Secteur Technologique Visibilité Des Investisseurs Médine Leaders Technologiques D'Euronext
PRESS RELEASE

published on 06/11/2024 at 09:00, 1 year 11 months ago

Inside Information / Other news releases
Medincell joins Euronext Tech Leaders, gaining access to a broad investor base and support services. CEO Christophe Douat highlights the company's growth and tech innovation leadership

Tech Sector Financial Strategy Investor Base Medincell Euronext Tech Leaders
PRESS RELEASE

published on 06/11/2024 at 09:00, 1 year 11 months ago

Informations privilégiées / Autres communiqués
Medincell rejoint l’indice Euronext Tech Leaders, accédant à un vaste écosystème et renforçant sa visibilité auprès d'investisseurs internationaux. La technologie BEPO® innovante de Medincell est reconnue

Croissance Innovation Medincell Euronext Tech Leaders BEPO®

Accesswire

Published on 05/13/2026 at 00:00, 1 hour 49 minutes ago

Onco-Innovations Announces Initiation of Research Collaboration within PROmAI
Published on 05/12/2026 at 23:35, 2 hours 14 minutes ago

Infield Minerals Closes $1.25 Million Financing
Published on 05/12/2026 at 21:55, 3 hours 54 minutes ago

UraniumX Discovery Corp Announces Option Agreement with Gold'n Futures
Published on 05/12/2026 at 21:42, 4 hours 7 minutes ago

Kidoz Inc. to Present at Planet MicroCap Las Vegas 2026
Published on 05/12/2026 at 14:30, 11 hours 19 minutes ago

Pathfinder Ventures Inc. Announces Conclusion of Financing and Intention to Launch New Private Placement

View all ACCESSWIRE

EQS Group

Published on 05/12/2026 at 23:47, 2 hours 2 minutes ago

Nebius welcomes Clarifai’s core team and licenses inference IP to strengthen Nebius Token Factory
Published on 05/12/2026 at 22:25, 3 hours 24 minutes ago

Evotec SE Successfully Placed €116.1 Million Convertible Bonds
Published on 05/12/2026 at 20:21, 5 hours 28 minutes ago

Nebius breaks ground on gigawatt-scale AI factory in Independence, Missouri
Published on 05/12/2026 at 19:35, 6 hours 14 minutes ago

AUSTRIACARD HOLDINGS AG: Q1 2026 Financial Results
Published on 05/12/2026 at 19:35, 6 hours 14 minutes ago

2026 Annual General Meeting: Strong vote by shareholders in favour of continuity in leadership and strategy

Les Echos

Published on 05/12/2026 at 18:15, 7 hours 34 minutes ago

AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 30/04/2026
Published on 05/12/2026 at 18:15, 7 hours 34 minutes ago

AXA: Information relating to the number of voting rights and shares making up the share capital on 30/04/2026
Published on 05/12/2026 at 18:10, 7 hours 39 minutes ago

imerys-12-05-2026-communiqué-compte-rendu-de-l-assemblée-générale-ordinaire-du-12-mai-2026
Published on 05/12/2026 at 18:10, 7 hours 39 minutes ago

imerys-12-05-2026-press-release-summary-of-the-ordinary-shareholders-general-meeting-12-may-2026
Published on 05/12/2026 at 17:50, 7 hours 59 minutes ago

Damartex fait évoluer sa gouvernance et engage une réflexion stratégique autour de ses activités

View all LES ECHOS COMFI WIRE